AEMD (Aethlon Medical Corp) Total Debt to Capital

Public company logo of Aethlon (AEMD)

The price history of Aethlon Medical (AEMD) on the GURU.Markets platform, where the indicator stands at 0.07, is based on the brand's waste recycling efforts and plant energy efficiency. High authority within the scientific community, driven by innovative plasma purification, supports the quotes. Growth prospects rely on the success of Hemopurifier filter clinical trials, the acquisition of new patents, and government funding.

AEMD: Aethlon Medical, Inc. Debt to Capital 07/04/2022 - 10/30/2026

Analytical breakdowns and data insights for company Aethlon Medical Corp (AEMD)

- stock quotes and analyst forecast:
Stock Quotes Aethlon Medical, Inc.|AEMD - Analyst Forecast Prices
- business market valuation indicators:
Market Capitalization Aethlon Medical|AEMD - Value Adjusted for Debt and Cash
- book capitalization indicators:
Book Value per Share Aethlon Medical|AEMD - Total Stockholders' Equity|Market Value to Book Value Ratio aethlonmedical.com|AEMD - Aggregate Asset Value
- company total debt and liquidity indicators:
Total Debt to Capital Aethlon Medical|AEMD - Long-Term Debt to Capital|Short-Term Debt to Equity Aethlon Medical|AEMD - Company Aggregate Indebtedness|Debts to Book Capitalization Aethlon Medical|AEMD - Long-Term Debt|Company Current Liabilities Aethlon Medical|Quick Liquidity Indicator aethlonmedical.com
- earnings and valuation multiples information:
AEMD - Profit After Payment of Taxes
Summary company analytics:Aethlon Medical, Inc., AEMD
Finished products of Aethlon Medical

This ratio measures the proportion of borrowed funds within the financing structure, determining the business's degree of financial autonomy and its resilience to market shocks. By analyzing changes in the total debt-to-equity ratio, investors assess the ability of Aethlon Medical (AEMD) to fund costly clinical trials and the implementation of blood purification filters without critical dependence on external creditors.

Competitors of Aethlon Medical

Total Debt to Equity Ratio DXCM|PEN (Penumbra Inc) - Aggregate Debt to Capital|Total Debt to Capital NOVT|HAE (Haemonetics Company) - All Debt to Shareholders' Equity Ratio|Total Debt to Capital INSP (Inspire Medical Systems)|procept-biorobotics.com (PRCT) - Debt to Capital|CNMD - Debt to Equity|All Debt to Shareholders' Equity Ratio PLSE (Pulse Biosciences Inc)|INMD: Total Debt to Capital|Picard Group (PMI) - Total Debt to Capital|Debt to Equity Surmodics, Inc.|Senseonics Corp - Aggregate Debt to Equity|Total Debt to Capital NPCE|TCMD - Debt to Capital|SANUWAVE Health, Inc. - Total Debt to Equity Ratio|Total Debt to Capital Outset Medical Corp OM|ELMD: Total Debt to Equity Ratio|lensar.com - Aggregate Debt to Capital|RCEL: Total Debt to Capital|PROF - Total Debt to Capital Coefficient|BDMD (Baird Medical Investment Holdings) - Total Debt to Capital|Total Debt to Equity Ratio EDAP Medical (EDAP)|Total Debt to Equity Ratio APYX (Apyx Medical)|ICCM (icecure-medical.com) - All Debt to Shareholders' Equity Ratio|Debt to Equity Pulmonx LUNG|TELA - Total Debt to Equity Ratio|CytoSorbents Corp. - Total Debt to Capital|Debt to Capital Sensus|ZYXI: Total Debt to Capital|Debt to Equity Ratio ECOR|RBOT (Vicarious Surgical Inc) - Total Debt to Capital|Inspira Technologies Oxy B.H.N. Ltd (IINN) - Total Debt to Capital Coefficient|Total Debt to Capital ICU|Total Debt to Equity Ratio iridex.com IRIX|Total Debt to Capital INBS (Intelligent Bio Solutions Inc.)|Total Debt to Capital Beyond Air Inc XAIR|PFSA - Debt to Equity|SSKN: Debt to Equity|GCTK (GlucoTrack) - Total Debt to Equity Ratio|NanoVibronix Inc. - All Debt to Shareholders' Equity Ratio|VERO (Venus Concept Inc.) - Total Debt to Capital|Debt to Capital nuwellis.com NUWE|Debt to Equity Asensus Surgical, Inc. (ASXC)|Avinger Inc. (AVGR) - Debt to Capital Ratio|BioSig Technologies, Inc. - Total Debt to Equity Ratio|Total Debt to Capital Cutera Inc CUTR|Know Labs, Inc. - Total Debt to Capital|Total Debt to Capital Coefficient inarimedical.com NARI|Nevro (NVRO) - Debt to Equity|Aggregate Debt to Equity RSLS (ReShape Lifesciences Inc.)|Debt to Equity Silk Road Medical Inc.